Company Monitoring Page for Novartis

latest headlines for company on cafepharma

What is Novartis without Sandoz? Vas Narasimhan is 'patient' as new company takes form
Endpoints
Tue, 10/25/22 - 11:13 pm
Tags:
Novartis, Pharma CEOs, Vas Narasimhan
Novartis sales of Zolgensma gene therapy slow as market shifts
BioPharma Dive
Tue, 10/25/22 - 11:02 pm
Tags:
Novartis, gene therapy, spinal muscular atrophy, SMA, Zolgensma
Novartis drops presbyopia drug acquired with Encore Vision
Pharmaphorum
Tue, 10/25/22 - 10:32 am
Tags:
Novartis, presbyopia, UNR844, Encore VIsion
Novartis, eyeing $3B market, beats AstraZeneca blood disorder blockbusters in phase 3
Fierce Biotech
Mon, 10/24/22 - 11:17 pm
Tags:
Novartis, iptacopan, clinical trials, Soliris, AstraZeneca, Ultomiris
Novartis’ oral drug iptacopan tops injectables in head-to-head PNH trial
Pharmaphorum
Mon, 10/24/22 - 10:47 am
Tags:
Novartis, iptacopan, clinical trials, PNH
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
CP WIre
Thu, 10/20/22 - 12:21 pm
Tags:
Novartis, Tasigna, generics, nilotinib, CML, Medicines Patent Pool
Thu, 10/20/22 - 12:19 pm
Tags:
Novartis, Tasigna, generics, nilotinib, CML, Medicines Patent Pool
Gene therapy is saving lives, but key challenges to realize its full potential
MedCity News
Thu, 10/20/22 - 10:30 am
Tags:
gene therapy, Novartis, Zolgensma, Roctavian, Zynteglo, Skysona
Novartis-partnered Orionis secures $55M to push cytokine program into clinic
Endpoints
Wed, 10/19/22 - 10:55 am
Tags:
Orionis Biosciences, Novartis, funding, R&D, cytokines
Novartis, GSK and Sanofi Scale Back on Operations and Labor Forces Overseas - Updated
BioSpace
Mon, 10/17/22 - 10:46 am
Tags:
Novartis, GSK, Sanofi, layoffs
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Fri, 10/14/22 - 10:40 am
Tags:
Novartis, Gilenya, generics, Supreme Court, MS, multiple sclerosis
Novartis to lay off 400 at Dublin campus amid global restructuring
Fierce Pharma
Fri, 10/14/22 - 10:05 am
Tags:
Novartis, Ireland, layoffs, restructuring
Novartis' Zolgensma Under Fire Again as Nature Retracts 2010 Paper
BioSpace
Wed, 10/12/22 - 11:45 pm
Tags:
Novartis, Zolgensma, data manipulation, SMA
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
Fri, 10/7/22 - 10:50 am
Tags:
ADHD, Adderall, drug shortages, Sandoz, Sun Pharma, Novartis
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
Tags:
layoffs, Cyclerion, OncoSec, Exicure, AbbVie, Bristol Myers Squibb, Palisade Bio, ObsEva, Rubius Therapeutics, Novartis, Finch Therapeutics
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
Tags:
FDA, GSK, Amicus Therapeutics, AstraZeneca, Novartis, Supernus, JNJ, Ipsen, Y-mAbs Therapeutics
Former Novartis drug for ultra-rare disease gets speedy FDA review
Endpoints
Wed, 09/28/22 - 10:58 am
Tags:
Pharming, Novartis, leniolisib, APDS, FDA
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Tags:
Takeda, JNJ, Novartis, ADHD, MHRA, Concerta XL, Ritalin XL, Equasym XL
PCSK9 pipeline shows signs of saturation
EP Vantage
Tue, 09/27/22 - 10:21 am
Tags:
AstraZeneca, ION449, Ionis Pharmaceuticals, Novartis, Leqvio, PCSK9 inhibitors
Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report
Fierce Pharma
Mon, 09/26/22 - 11:04 am
Tags:
Novartis, Eli Lilly, drug launches, Mounjaro

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.